Ocimum Biosolutions' Biotracker awarded caBIG Bronze Compatibility Certification

Ocimum Biosolutions today announced that its specialty life science Laboratory Information Management System (LIMS), Biotracker™ has been awarded the prestigious caBIG® (cancer Biomedical Informatics Grid®) Bronze Compatibility Certification by the National Cancer Institute, an institute of the National Institutes of Health, U.S. Department of Health and Human Services.

The overarching goal of the caBIG® program is to develop a truly collaborative information network that accelerates the discovery of new approaches for the detection, diagnosis, treatment, and prevention of cancer, ultimately improving patient outcomes. This is done by enabling collaboration between researchers by providing an interoperable IT infrastructure that facilitates data sharing. caBIG® provides a set of compatibility guidelines, covering computational interfaces and the semantic description of a data system, that provides detailed guidance on how to build a software system that will interoperate within the caBIG® framework.

Being granted a Bronze Compatibility Certification guarantees that Biotracker™ LIMS is compliant to the caBIG® guidelines in each of four areas: (1) Programmatic access to data; (2) Use of controlled vocabularies; (3) Use and accessibility of data elements and metadata; and (4) Availability of a diagrammatic representation of the information model used.

“A critical problem facing basic and clinical researchers today is the explosion of data and how to effectively manage and share this data,” states Dr. Howard J. Rosenberg, Executive Director of LIMS at Ocimum Biosolutions. “By attaining caBIG® Bronze Compatibility, Ocimum’s Biotracker™ LIMS provides the infrastructure and interoperability that is so critically needed to promote knowledge sharing and ultimately translational medicine,” affirms Dr. Rosenberg.


 Ocimum Biosolutions


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Researchers characterize a unique molecular mechanism of early stages of programmed cell death